跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
OTULFI 45 MG SOLUCIÓN INYECTABLE
Approved
STANDARD
OTULFI 45 MG SOLUCIÓN INYECTABLE
Fresenius Kabi Deutschland Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 16, 2025
Approval ID
d9d5f49e0a4cc9e4
Company
Fresenius Kabi Deutschland Gmbh
Type
Standard
Approval Details
Approval Id
d9d5f49e0a4cc9e4
Drug Cima Aemps Name
OTULFI 45 MG SOLUCIÓN INYECTABLE
Register Number
1241863004
Holder Company Name
Fresenius Kabi Deutschland Gmbh
Marketing Company Name
Fresenius Kabi España, S.A.U.
Holder Company Detail Path
/organization/fresenius-kabi-deutschland-gmbh
Authorization Date
2025-06-16
Dosage Form
SOLUCIÓN INYECTABLE
Dose
45 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Fresenius Kabi Deutschland Gmbh
Company Detail Path
/organization/fresenius-kabi-deutschland-gmbh
Company Information
Pharmaceutical Company Name
Fresenius Kabi Deutschland Gmbh
Country Name
Sweden
Address
Utländsk Adr - Foreign Addr
Website
http://www.fresenius-kabi.com
Active Ingredients
USTEKINUMAB
45 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 16, 2025
Approval ID
d9d5f49e0a4cc9e4
Type
Standard
Back to CIMA-AEMPS Approvals
OTULFI 45 MG SOLUCIÓN INYECTABLE - CIMA-AEMPS Drug Approval Details